Frontiers in Immunology (FI)
Journal Descriptions
Frontiers in Immunology is a multidisciplinary journal that publishes research across basic, translational, and clinical immunology. The journal aims to showcase advances and novel approaches to diagnosing and treating immune disorders in both animal and cellular models, as well as in humans. Indexed in MEDLINE, PubMed Central, Scopus and the SCIE Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Led by Field Chief Editor Luigi Daniele Notarangelo (Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, USA), Frontiers in Immunology welcomes contributions that investigate the basic mechanisms of immune system development and function, with a particular emphasis on describing the clinical and immunological phenotype of human immune disorders and defining their molecular basis. Frontiers in Immunology particularly welcomes news ideas and approaches which supports and advances the UN’s Sustainable Development Goal (SDGs), specifically SDG 3: good health and well-being. The research published in this journal could lead to the development of new treatments and therapies for various immunological disorders, thereby promoting well-being for all. Manuscripts that focus on clinical studies, medical treatments, or human diseases without a clear connection to immunology are not suitable for publication in this journal. Additionally, studies that use analytical molecular biology techniques without a clear immunological context or contribution to the field of immunology are also not within the scope of this journal.
Frontiers in Immunology (FI) is :-
-
International, Peer-Reviewed, Open Access, Refereed, multidisciplinary , Online , Monthly Journal
- UGC Approved, ISSN Approved: P-ISSN E-ISSN: 1664-3224, Established: 2024, Impact Factor: 9.4
- Provides Crossref DOI
-
Indexed in: Scopus, WoS, DOAJ, PubMed
-
Not indexed in UGC CARE
